|
|||
|
Multiple Sclerosis Info
|
Tuesday, March 4
Merck Serono Launches New Formulation Of Interferon Beta-1a
by
All About MS
on Tue 04 Mar 2008 08:21 AM CST
Merck Serono, a division of Merck KGaA, has announced that Rebif® New Formulation (interferon beta-1a) will be available in the UK. In a recent two-year (96 week) Phase IIIb study, 260 patients with relapsing remitting multiple sclerosis treated with the new formulation experienced a near three-fold more »
|
||
